Major cancer study aims to identify protein markers for early-stage disease

A team led by Bay Area scientists is one of five nationwide to receive a major grant from the National Cancer Institute (NCI) to refine and standardize the technologies for identifying biomarkers in the blood -- specific proteins, and the patterns they make -- for the early detection of cancer.

If you want to include this story in your blog, copy and paste this formatted text: